Director, Value Outcomes Liaison (VOL)

Summit Therapeutics

77d•$190,000 - $237,000•Remote

About The Position

Summit Therapeutics is seeking a Director, Value Outcomes Liaison (VOL), to join our mission of developing Ivonescimab, a novel and unique immunotherapy with the potential to help patients suffering from life-threatening cancers. The Director, VOL is a critical member of an expanding team, responsible for interfacing with US population-based decision makers (PBDMs) including payers, health systems, clinical pathway organizations, P&T committees, and policy makers. The VOL educates key stakeholders on clinical, economic, and humanistic impact of ivonescimab to help inform formulary access, pathway/guideline decisions, and improve lives of cancer patients. Providing objective and scientifically sound medical information on ivonescimab and the relevant disease states through use of economic models, outcomes tools, educational programs, and collaborations to enhance key stakeholder recognition of Summit Therapeutics. The VOL will compliantly partner with the commercial market access field team to facilitate access to ivonescimab through proactive engagement with organized customers, ensuring the delivery of accurate, non-promotional medical information.

Requirements

MD, PharmD, or PhD in Health Services Research, Health Economics, or related field
Minimum of 12+ years relevant experience in healthcare industry with minimum 5+ years direct experience in the pharmaceutical, managed care, or consulting industries
Previous experience in Oncology, preferably non-small cell lung cancer (NSCLC)
Previous experience in field-based role with strong understanding of the US healthcare system, market access landscape and value-based decision makers
Experience analyzing health care data and utilizing real-world evidence (RWE) is a plus
Strong analytical capabilities and excellent communication skills, including ability to communicate large amounts of scientific information in a manner that is clear, concise and memorable
Ability to work collaboratively across diverse teams and manage multiple stakeholders with ability to influence and collaborate to make a business impact
Ability to be proactive, enthusiastic and goal oriented

Responsibilities

Independently cultivate and manage relationships with PBDMs, acting as primary point of contact and collaborating closely with other field roles to ensure an aligned approach to stakeholder engagement
Collaborate with internal HEOR team and market access team, to execute on scientific engagement strategy for appropriate stakeholders (e.g., Payers, PBMs, GPOs, IDNs and Oncology Pathways) within a territory or customer base
Serve as a conduit and resource for providing clinical and healthcare economic information (HCEI) to payers and formulary decision-makers
Maintaining required knowledge of ivonescimab, to proactively and reactively communicate clinical and economic information related to ivonescimab to advance formulary decision-making and improve patient outcomes
Capture and communicate internally key stakeholder insights and evidence gaps/needs including potential opportunities for collaboration
Understand the medical affairs priorities to contribute to content strategy development and execute aligned field tactics
Work with stakeholders to ensure inclusion of ivonescimab in clinical/payer pathways, and treatment order sets, while optimizing budget assessments.
Collaborate effectively with medical affairs, HEOR, market access and other colleagues as appropriate in support of developing and implementing account engagement plan, providing input on scientific and value topics
Understanding of principles of study design, methodology, data analysis, and interpretation to successfully communicate data to stakeholders
Utilize and effectively present clinical, humanistic, and economic evidence as well as the value proposition in a clear and compelling manner to the payer audience
Maintain understanding of market and payer needs in an increasingly complex and dynamic environment to drive actionable recommendations to inform medical and market access strategy
All other duties as assigned